Week of April 11, 2022 | Vol. 11, Issue 15
Events Hosted or Attended by Bourne Partners
May 17-19, 2022 - Philadelphia, PA
May 24-26, 2022 - New York City, NY
April 23-26, 2022 - Palm Beach, FL
June 13-16, 2022 - San Diego, CA
August 27-29, 2022 - Boston, MA
October 2022 - Charlotte, NC
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Gateway
Sell-side | Pharma | Generic pharmaceuticals

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
With billions of dollars pouring into healthcare every year and countless new technologies emerging, healthcare businesses in the U.S. are thriving.
In a deal nearly two years in the making, Bioventus has opted to acquire fellow orthopedic devicemaker CartiHeal—less than a week after CartiHeal announced its flagship cartilage repair implant Agili-C had been approved by the FDA.
Regenerative medicine couldn't stop making news in 2021. The year was marked by Intellia's first results in humans for gene editing, massive Big Pharma partnerships and record investment of $22.7 billion.
To help boost its drug discovery and development work in cardiovascular disease, Valo Health is acquiring TARA Biosystems, makers of a 3D heart tissue modeling platform.

TannerMAP works across the broad spectrum of pharma services, creating opportunities that benefit manufacturers and patients alike. Learn more about the division from industry veterans and Tanner EVPs, Rob Keel and John Lagus.

When demand for PPE and testing kits surged to unparalleled levels in March 2020 during the first wave of Covid-19, Tanner had to do something to help. Learn more about the development of TannerGMS (global medical supplies) and the future of medical supplies and diagnostics here.

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.